首页>
外国专利>
PEPTIDES MODIFIED AT THEIR N-TERMINAL BOND, METHOD OF OBTAINING THEM AND THEIR APPLICATIONS AS THERAPEUTIC AGENTS
PEPTIDES MODIFIED AT THEIR N-TERMINAL BOND, METHOD OF OBTAINING THEM AND THEIR APPLICATIONS AS THERAPEUTIC AGENTS
展开▼
机译:在其N末端键上修饰的肽,获得它们的方法及其在治疗剂中的应用
展开▼
页面导航
摘要
著录项
相似文献
摘要
Peptides of the formula I Z - P - A - B - C - E - F - K - (D)Q - G- M- F' - I (I), in which Z is optionally substituted (cyclo)alk(ano)yl(sulphonyl), (C1-C8)-alkoxycarbonyl, (hetero)ar(o)yl(sulphonyl), carbamoyl, P is a direct linkage or a radical II -NR2-(U)-CO- (II in which R2 is H, methyl or a urethane protective group, U is (cyclo)(aryl)alkylidene, (hetero)arylidene or (CHR3)n, R3 is hydrogen, (cyclo)alkyl, (hetero)aryl, or in which R2 and R3 form, together with the atoms carrying them, a ring system; A is defined as P; B is a basic amino acid in the L or D configuration, C is a compound of the formula IIIa or IIIb G'-G'-Gly (IIIa G'-NH-(CH2)p-CO (IIIb in which p is 2 to 8 and G' are, independently of one another, a radical of the formula IV -NR4-CHR5-CO- (IV in which R4 and R5 form, together with the atoms carrying them, a heterocyclic ring system; E is the residue of a neutral, acid or basic, aliphatic or alicyclic-aliphatic amino acid; F are, independently of one another, the radical of a neutral, acid or basic, aliphatic or aromatic amino acid, or a direct linkage; (D)Q is D-Tic, D-Phe, D-Dic, D-Thi or D-Nal, or a radical of the formula (V) IMAGE in which X is O, S or a direct linkage, and R is H, (cyclo)alkyl or aryl(alkyl), G is defined as G' above or is a direct linkage; F' is defined as F, is a radical -NH-(CH2)q- with q = 2 to 8 or, if G is not a direct linkage, can be a direct linkage, and I is -OH, -NH2 or NHC2H5; K is the radical -NH-(CH2)x-CO- with x = 1-4 or is a direct linkage, and M is defined as F and their physiologically tolerated salts are described. They have excellent bradykinin-antagonistic action. They are obtained by reacting a fragment with a C-terminal free carboxyl group or its activated derivative with an appropriate fragment with an N-terminal free amino group, or by assembling the peptide stepwise, eliminating one or more protective groups temporarily introduced where appropriate to protect other functionalities in the compound obtained in this way, and converting the compounds of the formula I obtained in this way where appropriate into their physiologically tolerated salt.
展开▼